This is the headline of a July 2021 Focus Online article.<\/p>\n
As it is known, almost 85% of the population have Epstein Bar Virus (EBV)<\/strong> in them without feeling any symptoms. Others have very severe symptoms of lymphatic swelling, headache, sore throat, liver strain, swelling of the spleen, and deep prolonged fatigue (so-called CFS).<\/p>\n Researchers led by Jeffrey Gold of the World Organization in the USA have now investigated (see Study: https:\/\/www.mdpi.com\/2076-0817\/10\/6\/763)<\/a>, which role reactivation may play in long covid patients or also influence the intensity of covid disease.<\/p>\n It was observed that the symptoms of the patients are very similar, such as fatigue, headache, fever, as well as neurological disorders and so on. In Long Covid patients, an increased reactivation (66.7% according to the study) was observed in the blood.<\/p>\n According to the research team, ganciclovir is a suitable treatment. One of the few antiviral agents in the pharmaceutical industry.<\/p>\n Alternative medicine<\/strong> has also taken an interest in the subject. For example, microimmunotherapy has been dealing with the (re)activation of EBV in the blood for a very long time and as its main focus. What are the reasons and how can (re)activation be contained and sustainably influenced?<\/p>\n Strengthening the immune system through microimmunotherapy is one approach.<\/p>\n Interested to learn more?<\/p>\n Contact us. Book appointment now.<\/a><\/p>\n The pharmacist recommends to her clients in case of viral infection: Labo Life 2L EID<\/a> | OMNI BiOTiC Pro-VI 5<\/a><\/p>\n Promotion: 2l MIREG<\/p>\nLong Covid & EBV Research from the USA<\/h3>\n